findmyKOL
Clinical trialNCT05985083UnknownPhase 1Interventional

A Study Of IMM47 In Subjects With Advanced Solid Tumors

SponsorImmuneOnco Biopharmaceuticals (Shanghai) Inc.Enrollment48Oncology
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Macquarie University Clinical Trials Unit (mq Ctu)

    Sydney, New South Wales, Australia

    Not, yet, recruiting
  • Scientia Clinical Research Ltd, Nsw

    Sydney, New South Wales, Australia

    Recruiting
  • Icon Cancer Centre South Brisbane, Qld

    Brisbane, Queensland, Australia

    Recruiting
  • John Flynn Private Hospital

    Gold Coast, Queensland, Australia

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Aug 2023
Primary completion
26 Dec 2024
Completion
23 Jan 2025
Last update posted
4 Oct 2023
Registered enrollment
48
Registry id
NCT05985083

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.